Szczegóły obiektu: Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines

Instytucja dostarczająca:Repozytorium Uniwersytetu Łódzkiego

Opis

Tytuł:
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines
Twórca:
Rogalska, Aneta
Współtwórca:
Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236, Lodz, Poland.;
aneta.rogalska@biol.uni.lodz.pl
Description:
Epithelial ovarian cancer (EOC) remains a leading cause of gynecologic cancer mortality. Despite advances in treatment, metastatic progression and resistance to standard therapies significantly worsen patient outcomes. Epithelial-mesenchymal transition (EMT) is a critical process in metastasis, enabling cancer cells to gain invasive and migratory capabilities, often driven by changing miRNA expression involved in the regulation of pathological processes like drug resistance. Targeted therapies like PARP inhibitors (PARPi) have improved outcomes, particularly in BRCA-mutated and DNA repair-deficient tumors; however, resistance and limited efficacy in advanced stages remain challenges. Recent studies highlight the potential synergy of PARPi with DNA damage response (DDR) inhibitors, such as ATR and CHK1 inhibitors, which disrupt cancer cell survival pathways under stress. This study investigated the combined effects of olaparib with ATR and CHK1 inhibitors (ATRi and CHK1i) on migration, invasion, and EMT-related protein expression and miRNA expression in ovarian cancer cell lines OV-90 and SKOV-3. The results demonstrated enhanced cytotoxicity, inhibition of migration and invasion, and modulation of miRNAs linked to metastasis. These findings suggest that combination therapies targeting DNA repair and cell cycle pathways may offer a novel, more effective approach to managing advanced EOC and reducing metastatic spread.;
National Science Centre, Poland (project grant number: Sonata Bis 2019/34/E/NZ7/00056).
Object availability:
Dostęp otwarty
Rights:
CC0 1.0 uniwersalna;
http://creativecommons.org/publicdomain/zero/1.0
Date:
2025.02.27;
2025
Type:
Dataset
Format:
application/octet-stream
Subject:
DDR inhibitors;
EMT;
PARPi;
miRNA;
ovarian cancer
Identifier: http://hdl.handle.net/11089/54820
Data provider:
Repozytorium Uniwersytetu Łódzkiego

Podobne obiekty

Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines

Twórca:Rogalska, Aneta

Data:2025.02.27 | 2025

Rodzaj zawartości:teksty

The role of microRNAs in animal physiology and pathology

Twórca:Szczepanek, Joanna | Pareek, Chandra S. | Tretyn, Andrzej

Data:2018.12.28

Rodzaj zawartości:teksty

MiRNA expression profile in serum of osteoarthritis patients

Data:2019.11.04

Rodzaj zawartości:teksty

Rola miRNA w toksyczności nanocząstek srebra

Twórca:Paciorek, Patrycja

Data:2023.09.27 | 2023

Rodzaj zawartości:teksty

Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors, Sonata Bis 2019/34/E/NZ7/00056, Sonata Bis-9 (dataset)

Twórca:Rogalska, Aneta

Data:2024.07.02 | 2024

Rodzaj zawartości:teksty

Potential in anti-cancer therapy using RNA - overview of therapies

Twórca:Rusinowska, Barbara

Data:2022.07.28

Rodzaj zawartości:teksty

Genetic technology in the targeted therapy of Alport Syndrome

Twórca:Kłusek, Magdalena | Pawłowski, Bartosz | Sienkiewicz, Michał | Mandziuk, Anna

Data:2025.02.13

Rodzaj zawartości:teksty

Konstrukcja i adnotacje sygnatur genowych na bazie eksperymentów porównawczych uzyskiwanych technikami wysokoprzepustowymi w biologii molekularnej

Twórca:Łabaj, Wojciech

Data:2019.12.31 | 2019

Rodzaj zawartości:teksty

Federacja Bibliotek Cyfrowych

Szczegóły obiektu: Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines

Opis

Podobne obiekty